Earnings call analysis

The Cigna (CI) Q3 2026 Earnings Call: Guidance and Outlook

Cigna provided updated full-year 2026 guidance and preliminary directional comments for 2027.

About The Cigna. Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments.

Call date

Nov 5, 2026

Sentiment score

+35 Balanced

Management tone, -100 to +100

Sentiment change

vs Q2 2026 call

Sector

Health Care, Health Care Providers and Services

Next report

Feb 4, 2027

View calendar

Quarterly guidance

Quarterly guidance: No quarterly guidance was given.

Annual guidance

Full year 2026 adjusted EPS: At least $30.60
Full year 2026 Evernorth pretax adjusted earnings: At least $6.9 billion
Full year 2026 Cigna Healthcare pretax adjusted earnings: At least $4.6 billion
Full year 2026 MCR: 84.2% plus or minus 25 basis points

Outlook

2027 EPS Growth: Expected to be at least 10% off a 2026 run rate of approximately $30.
Cigna Healthcare 2027: Adjusted income from operations expected to grow within the long-term target of 6% to 9%.
Specialty and Care Services 2027: Adjusted earnings expected to grow within the 8% to 12% long-term target range, though towards the low end.
Pharmacy Benefit Services 2027: Expected to face headwinds, including industry-wide rebate compression and lower employer coverage of GLP-1s.
Accelerate to One: Initiative expected to contribute $3 billion in gross run rate savings by 2030.
ACA Exchange Exit: Expected to represent an approximately $200 million headwind in 2027.

Sources and method

Dombey's summary of the The Cigna Q3 2026 earnings call held Nov 5, 2026, written from the call itself. Every figure on this page was checked against what was said on the call, and quoted lines are management's own words; we do not add estimates or prices. The tone score is our read of management's wording, guidance and answers. Check figures against the company's SEC filings before acting. This is research, not investment advice.

Updated Nov 9, 2026. All earnings call analyses

Research access

Research published before the catalyst, kept on the record after it.

Free AccountComplimentaryA DombeyAI account at no cost: the daily market view, earnings call analysis, a watchlist and every published pick tracked from the day it was named.Create a free account Standard Access$6.67 / monthOngoing catalyst coverage and the complete public-research archive, for readers who want to follow forthcoming events and revisit the firm's published thinking.Start Standard Access RecommendedFounding Membership$1,200 / yearInstitutional access to the complete research suite, proprietary models and execution strategy.Become a Founding Member